Improving Compliance With Metformin

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions

NCT00778427 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Subjects

NCT00944177 ·Status: COMPLETED ·Phase: PHASE1

Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS

NCT02087826 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting Conditions

NCT00865852 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions

NCT00778466 ·Status: COMPLETED ·Phase: NA

Tolerability Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets

NCT07300046 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

The Interaction Between Metformin and Microbiota - the MEMO Study.

NCT03718715 ·Status: UNKNOWN

A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants

NCT03467971 ·Status: COMPLETED ·Phase: PHASE1

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

NCT00519142 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition

NCT01160042 ·Status: COMPLETED ·Phase: PHASE1

Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool

NCT04383041 ·Status: COMPLETED

Effects of Metformin During Nicotine Withdrawal

NCT03593538 ·Status: COMPLETED ·Phase: PHASE2

Study to Compare the Bioavailability of Extended Release Metformin HCl Tablet Versus Glucophage XR® Tablets in Healthy Human Volunteers Under Fasting Condition

NCT01089166 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Two Strengths of Two Different Metformin Tablets Administered to Healthy Male and Female Subjects

NCT02183571 ·Status: COMPLETED ·Phase: PHASE1

Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans

NCT01762046 ·Status: COMPLETED ·Phase: PHASE1

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers

NCT05549583 ·Status: COMPLETED ·Phase: PHASE1

Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers

NCT05549570 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design

NCT00798161 ·Status: COMPLETED ·Phase: PHASE3

A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting Conditions

NCT00865072 ·Status: COMPLETED ·Phase: PHASE1

Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets

NCT07300059 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.

NCT01842620 ·Status: COMPLETED ·Phase: PHASE4

Study to Test Use of a Decision Aid in a Clinical Visit to Help Patients Choose a Diabetes Medication

NCT01293578 ·Status: COMPLETED ·Phase: NA

Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition

NCT01831661 ·Status: COMPLETED ·Phase: PHASE1

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting

NCT00835497 ·Status: COMPLETED ·Phase: PHASE1

Comparative Bioavailability Study of Metformin HCl 1000 mg Granules vs Glucophage 1000 mg Film-coated Tablet

NCT02217670 ·Status: WITHDRAWN ·Phase: PHASE1